Burling Wealth Partners’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
4,824
-16
-0.3% -$3.33K 0.17% 95
2026
Q1
$1.02M Sell
4,840
-406
-8% -$87.4K 0.17% 94
2025
Q4
$1.08M Sell
5,246
-28
-0.5% -$5.27K 0.17% 91
2025
Q3
$828K Sell
5,274
-699
-12% -$108K 0.14% 105
2025
Q2
$1M Sell
5,973
-1,006
-14% -$149K 0.19% 97
2025
Q1
$961K Sell
6,979
-611
-8% -$77.9K 0.2% 94
2024
Q4
$898K Buy
+7,590
New +$886K 0.18% 98

Other funds holding CAH

Burling Wealth Partners's CAH Position: Q2 2026 in Review

Burling Wealth Partners reduced its Cardinal Health (CAH) stake by 0.33% in Q2 2026, selling an estimated $3.33K and leaving 4,824 shares worth $1.15M. The position accounts for 0.17% of the portfolio, ranked #95.

Burling Wealth Partners first reported a position in CAH in Q4 2024 and has held it in 7 quarters since. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Burling Wealth Partners held 4,824 shares of Cardinal Health worth $1.15M as of Q2 2026.
  • Burling Wealth Partners sold 16 Cardinal Health shares in Q2 2026, an estimated $3.33K.
  • Cardinal Health made up 0.17% of Burling Wealth Partners's portfolio in Q2 2026, its #95 holding.
  • Burling Wealth Partners first reported a position in Cardinal Health in Q4 2024 and has held it in 7 quarters since.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Burling Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.